BioCentury | Nov 22, 2019
Finance

Syncona backs Cambridge oncology spinout Azeria in £32M series B

...fully invested, by virtue of its £29.5 million commitment. The balance will come from the Cancer Research Technology...
BioCentury | Nov 21, 2019
Clinical News

Syncona backs Cambridge oncology spinout Azeria in £32M series B

...fully invested, by virtue of its £29.5 million commitment. The balance will come from the Cancer Research Technology...
BioCentury | Jul 18, 2019
Distillery Therapeutics

Inhibition of BACH1 or the genes it controls for metastatic lung cancer

...tool compound inhibitors of HMOX1 and GADPH decreased the number of metastases. AstraZeneca plc and Cancer Research Technology Ltd....
BioCentury | Dec 15, 2017
Emerging Company Profile

CD38 hat trick

...2015 by Droia Oncology Ventures and Luc Dochez University collaborators: University College London Corporate partners: Cancer Research Technology Ltd....
BioCentury | Nov 17, 2017
Company News

Sixth Element, PhoreMost spin out immuno-oncology newco

...$93.2 million) Cancer Research Technology Pioneer Fund. NeoPhore Ltd., Cambridge, U.K. PhoreMost Ltd., Cambridge, U.K. Business: Cancer Allison Johnson Cancer Research Technology...
BioCentury | Nov 2, 2017
Targets & Mechanisms

Golden State of DUBs

...mouse model. The study was performed by an alliance created by Forma in 2013 with Cancer Research Technology Ltd....
...LLC, New Haven, Conn. C4 Therapeutics Inc., Cambridge, Mass. Calico LLC, South San Francisco, Calif. Cancer Research Technology Ltd....
BioCentury | Aug 29, 2017
Company News

Forma adds $195M cash after Celgene extends collaboration

...also has deals with Johnson & Johnson (NYSE:JNJ), Boehringer Ingelheim GmbH (Ingelheim, Germany) and the Cancer Research Technology Ltd....
BioCentury | Jul 20, 2017
Finance

Sharpless edge for NCI

...19 NIH To boost research targeting Ras in cancer treatment, Cancer Research UK and the Cancer Research Technology...
BioCentury | Jul 14, 2017
Company News

Cancer Research UK and Merck KGaA extend 2015 deal to discover Hippo-YAP pathway therapies

...The Cancer Research Technology (CRT) commercial arm of Cancer Research UK (London, U.K.) said it extended a 2015...
...for publication. Cancer Research UK , London, U.K. Merck KGaA (Xetra:MRK), Darmstadt, Germany Business: Cancer Alex Himes Cancer Research Technology Cancer...
BioCentury | Jul 7, 2017
Company News

Merck KGaA spins out cancer newco iOnctura with partner Cancer Research UK

...of Merck’s Healthcare R&D portfolio, and exclusive, worldwide options to three unnamed assets from the Cancer Research Technology...
Items per page:
1 - 10 of 208
BioCentury | Nov 22, 2019
Finance

Syncona backs Cambridge oncology spinout Azeria in £32M series B

...fully invested, by virtue of its £29.5 million commitment. The balance will come from the Cancer Research Technology...
BioCentury | Nov 21, 2019
Clinical News

Syncona backs Cambridge oncology spinout Azeria in £32M series B

...fully invested, by virtue of its £29.5 million commitment. The balance will come from the Cancer Research Technology...
BioCentury | Jul 18, 2019
Distillery Therapeutics

Inhibition of BACH1 or the genes it controls for metastatic lung cancer

...tool compound inhibitors of HMOX1 and GADPH decreased the number of metastases. AstraZeneca plc and Cancer Research Technology Ltd....
BioCentury | Dec 15, 2017
Emerging Company Profile

CD38 hat trick

...2015 by Droia Oncology Ventures and Luc Dochez University collaborators: University College London Corporate partners: Cancer Research Technology Ltd....
BioCentury | Nov 17, 2017
Company News

Sixth Element, PhoreMost spin out immuno-oncology newco

...$93.2 million) Cancer Research Technology Pioneer Fund. NeoPhore Ltd., Cambridge, U.K. PhoreMost Ltd., Cambridge, U.K. Business: Cancer Allison Johnson Cancer Research Technology...
BioCentury | Nov 2, 2017
Targets & Mechanisms

Golden State of DUBs

...mouse model. The study was performed by an alliance created by Forma in 2013 with Cancer Research Technology Ltd....
...LLC, New Haven, Conn. C4 Therapeutics Inc., Cambridge, Mass. Calico LLC, South San Francisco, Calif. Cancer Research Technology Ltd....
BioCentury | Aug 29, 2017
Company News

Forma adds $195M cash after Celgene extends collaboration

...also has deals with Johnson & Johnson (NYSE:JNJ), Boehringer Ingelheim GmbH (Ingelheim, Germany) and the Cancer Research Technology Ltd....
BioCentury | Jul 20, 2017
Finance

Sharpless edge for NCI

...19 NIH To boost research targeting Ras in cancer treatment, Cancer Research UK and the Cancer Research Technology...
BioCentury | Jul 14, 2017
Company News

Cancer Research UK and Merck KGaA extend 2015 deal to discover Hippo-YAP pathway therapies

...The Cancer Research Technology (CRT) commercial arm of Cancer Research UK (London, U.K.) said it extended a 2015...
...for publication. Cancer Research UK , London, U.K. Merck KGaA (Xetra:MRK), Darmstadt, Germany Business: Cancer Alex Himes Cancer Research Technology Cancer...
BioCentury | Jul 7, 2017
Company News

Merck KGaA spins out cancer newco iOnctura with partner Cancer Research UK

...of Merck’s Healthcare R&D portfolio, and exclusive, worldwide options to three unnamed assets from the Cancer Research Technology...
Items per page:
1 - 10 of 208